12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Serada gabapentin GR regulatory update

FDA's Advisory Committee for Reproductive Health Drugs will meet on March 4 to discuss an NDA from...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >